[SCHEDULE 13G/A] agilon health, inc. SEC Filing

Rhea-AI Filing Summary

Capital International Investors reported beneficial ownership of 9,892,742 shares of agilon health common stock, equal to 2.4% of 413,951,779 shares outstanding. CII is presented as a division of Capital Research and Management Company and affiliated investment management entities and states it has sole voting and sole dispositive power over those 9,892,742 shares with no shared power. The disclosure is filed on a Schedule 13G/A as an IA (investment adviser) and the filing notes this is an ownership position of 5% or less. The signer certifies the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Insights

Financial Analyst

TL;DR: Institutional investor reports a modest 2.4% passive stake with sole voting and dispositive power; not a control position.

The filing shows Capital International Investors beneficially owns 9,892,742 shares of agilon health, representing 2.4% of the 413,951,779 shares the filing cites as outstanding. The holder reports sole voting and dispositive authority for the full position and files on Schedule 13G/A as an investment adviser, which is consistent with passive disclosure requirements. Because the stake is under 5% and the certification states the position is held in the ordinary course and not to influence control, the holding is unlikely to materially affect agilon's governance or near-term valuation.

Corporate Governance Expert

TL;DR: Governance impact appears minimal: no shared power, no group affiliation, certification denies control intent.

The statement specifies zero shared voting or dispositive power and does not identify any group or subsidiary acquiring the securities, reducing the likelihood of coordinated governance action. The filer classifies itself as type IA (investment adviser) and includes the standard certification that the securities are not held to change or influence control. From a governance perspective, this disclosure documents institutional ownership but does not signal active engagement or a control attempt.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

agilon health, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

00857U107

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 00857U107

1

Names of Reporting Persons

Capital International Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 9,892,742.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 9,892,742.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,892,742.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.4 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: agilon health, Inc.
(b)	Address of issuer's principal executive offices: 6210 E HWY 290, SUITE 450, AUSTIN, TX 78723
Item 2.
(a)	Name of person filing: Capital International Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 00857U107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 9,892,742 ** **Capital International Investors ("CII") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CII's divisions of each of the investment management entities collectively provide investment management services under the name "Capital International Investors." CII is deemed to be the beneficial owner of 9,892,742 shares or 2.4% of the 413,951,779 shares believed to be outstanding.
(b)	Percent of class: 2.4 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 9,892,742
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 9,892,742
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital International Investors

Signature:	Jae Won Chung
Name/Title:	Vice President and Senior Counsel II, Capital Research and Management Company
Date:	08/12/2025

FAQ

What stake does Capital International Investors report in agilon health (AGL)?

Capital International Investors reports beneficial ownership of 9,892,742 shares, representing 2.4% of 413,951,779 shares outstanding.

Does Capital International Investors share voting or dispositive power over the reported shares?

No. The filing reports sole voting power and sole dispositive power for 9,892,742 shares and 0 shared voting or dispositive power.

Under which SEC form and classification was this disclosure filed for AGL?

The disclosure was made on a Schedule 13G/A and the reporting person is classified as an IA (investment adviser).

Is the Capital International stake in agilon health greater than 5%?

No. Item 5 indicates ownership of 5 percent or less of the class; the reported stake is 2.4%.

Who signed the Schedule 13G/A on behalf of Capital International Investors?

The filing is signed by Jae Won Chung, Vice President and Senior Counsel II at Capital Research and Management Company.